The economic impact of bogus vaccine policy. Not to mention the suffering.
Wendy
14 Likes
The HPV vaccine referenced in the article is still recommended by HHS. The change is from 2 or 3 doses to a single dose for children. The statement that there is insufficient evidence to reduce the dosage is interesting given 6 or so peer nations have made a similar recommendation to reduce the dose to 1 on the research and in advance of the US decision. It’s odd the decisions by these nations drew little criticism.
2 Likes
Did those nations also change measles vaccination schedules? Are they all adopting the same anti-vax policies the US is pushing?
There’s no doubt that vaccination schedules should be continously monitored by experts. The US is not being guided by experts anymore. That’s the point of the article.
12 Likes
Covid revealed policy was not following the science. It was actually suppressing it. The natural reaction and consequence is a skepticism of the existing policies. The article is by a healthcare executive with zero clinical research experience with vaccines. It’s an unqualified opinion, of no more value than yours or mine.
Kennedy is questioning, pushing back, and most of all telling parents to consult with their physicians. You think the last administration was guided by objective expertise. Scott Gotleib worked for the FDA and joined Pfizer’s board. He then began instructing govt officials on the COVID policy and encouraging them to censor alternative therapies. Pfizer hit a record in revenue of 100 billion by 2022 and Scott started making 5x what he made at the FDA.
Nobody in power was following the experts, they were following the money.
2 Likes
The interesting thing, @eldemonio , is that, as you pointed out, vaccine policy undergoes frequent revision. One of the features to be factored in with these blanket statements about what “other countries“ do, is how many of the population of those other countries are vaccinated and how prevalent is the disease among those countries. That makes a big difference to the efficacy of dosing schedules. In a country like, say Australia, …….that has had a phenomenal success in HPV vaccine uptake that they’re on track for eradicating cervical cancer (and presumably others that accompany HPV infection)…..can probably well afford to test whether a reduction in doses over the past few years will be adequate to prevent re-emergence over future decades. It’s an experiment I’d sooner watch from a distance rather than participate in.
We do not have that luxury in the US. Anti vaxx sentiments are so prevalent and so entrenched that resistance to Gardisil has always been huge. I had to point out a few facts on this count to a fellow Rotarian a couple of years ago (not the flu vaccine bloke) One of his bamboozle phrases …..probably culled from an AI overview…..was follow the money.
8 Likes